Re: CYP2D6 genotyping and the use of tamoxifen in breast cancer
J Natl Cancer Inst
.
2014 Feb;106(2):djt379.
doi: 10.1093/jnci/djt379.
Epub 2014 Jan 9.
Authors
Michael A Province
1
,
Teri E Klein
;
International Tamoxifen Pharmacogenomics Consortium
Affiliation
1
Affiliations of authors: Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO (MAP); PharmGKB, Stanford University, Palo Alto, CA (TEK).
PMID:
24408655
PMCID:
PMC4067108
DOI:
10.1093/jnci/djt379
No abstract available
Publication types
Letter
Comment
MeSH terms
Breast Neoplasms / enzymology*
Breast Neoplasms / genetics*
Cytochrome P-450 CYP2D6 / genetics*
Cytochrome P-450 CYP2D6 / metabolism*
DNA, Neoplasm*
Female
Humans
Substances
DNA, Neoplasm
Cytochrome P-450 CYP2D6
Grants and funding
R24 GM061374/GM/NIGMS NIH HHS/United States